Daily BriefsMost Read

Most Read: JMDC , JFE Holdings, Evolution Mining, Eoflow , SK Square , Western Superconducting Techno, Youngpoong Paper Mfg, Innovent Biologics Inc, I-NE , Poly Culture Group Corp H and more

In today’s briefing:

  • Omron Partial Offer for JMDC (4483) – The Engagement Is On! This Is the Script, This Is the Timing
  • JFE Holdings (5411) – Volume Patterns Indicate Possible Squeeziness
  • MVIS Global Junior Gold Miners Index Rebalance: One Add, One Delete, Float, Capping = Big Impact
  • Merger Arb Mondays (11 Sep) – Eoflow, Mason, Liontown, Newcrest, United Malt, OreCorp, MPI
  • KRX Sector Index Series Rebalancing: Heavy Shorting on SK Square Is Anticipated
  • CSI500 Index Rebalance Preview: ETF Inflows Lead to Performance Skew
  • KOSPI Size Indices – Changes in September & Implications
  • Innovent Biologics Placement – Has Ample Cash but the Discount Is Enticing
  • I-Ne (4933) Offering Priced, Now to a TOPIX Inclusion
  • Poly Culture (3636 HK): Pre-Condition Fulfilled


Omron Partial Offer for JMDC (4483) – The Engagement Is On! This Is the Script, This Is the Timing

By Travis Lundy

  • In February 2022, Noritsu Koki (7744 JP) sold a chunk of JMDC (4483 JP) to Omron Corp (6645 JP) for nearly US$1bn. 7mos later, Omron supported a primary offering.
  • Now Omron is going to 50+%, as Noritsu Koki is getting out. Other investors have to participate for this to succeed. 
  • The question of pro-ration may be a question of Elmer vs Mr Partridge. But Elmer has a point here. 

JFE Holdings (5411) – Volume Patterns Indicate Possible Squeeziness

By Travis Lundy

  • On 5 September, JFE Holdings (5411 JP) saw an article out of a capital raising. It was confirmed later in the day. Huge volumes traded. The stock fell sharply.
  • The offering supply/demand dynamics are…. complicated. The offering is to foreign instos. The net demand is probably mostly retail and index, and positioning is… also complicated.
  • The EPS dilution is already accounted for. The fall against Nippon Steel pretty much does it after considering the discount expected. 

MVIS Global Junior Gold Miners Index Rebalance: One Add, One Delete, Float, Capping = Big Impact

By Brian Freitas



KRX Sector Index Series Rebalancing: Heavy Shorting on SK Square Is Anticipated

By Sanghyun Park

  • The most noteworthy developments include Samsung Electronics being newly added to the Semicon sector, while SK Square has been removed.
  • We must be mindful of the potential concentration of shorting flow on SK Square as most names expected to experience negative flows do not fall under the KS200/KQ150 membership.
  • Our strategic approach can take three directions: 1. aim at only those receiving positive flows, 2. heavy shorting SK Square, and 3. long-short the four with the most flow size.

CSI500 Index Rebalance Preview: ETF Inflows Lead to Performance Skew

By Brian Freitas

  • Over 85% of the way through the review period for the December rebalance of the CSI500 Index, we forecast 50 changes (the maximum permitted) at the close on 8 December.
  • There is a big sector skew in the potential changes. We estimate a one-way turnover of 9.4% at the December rebalance resulting in a one-way trade of CNY 7.22bn.
  • With the market being stabilised through the ETF route, the index constituents have outperformed the non-index constituents over the last 6-7 weeks. That could reverse over the near term.

KOSPI Size Indices – Changes in September & Implications

By Brian Freitas

  • There are 8 migrations from MidCap to LargeCap, 7 LargeCap to MidCap, 8 new additions to MidCap, 17 SmallCap to MidCap, 23 MidCap to SmallCap, 5 new additions to SmallCap.
  • The migrations from SmallCap to MidCap have outperformed the stocks migrating between other segments by a huge margin over the last few months.
  • Given the huge outperformance and looking at how the migrations have performed historically, we’d expect the stocks migrating to MidCap to underperform post implementation of the changes.

Innovent Biologics Placement – Has Ample Cash but the Discount Is Enticing

By Sumeet Singh

  • Innovent Biologics Inc (1801 HK) (IB) aims to raise around US$313m for R&D and marketing.
  • The company has undertaken a number of deals in the past, with the overall results being mixed.
  • In this note, we will talk about the deal dynamics and run the deal through our ECM framework.

I-Ne (4933) Offering Priced, Now to a TOPIX Inclusion

By Travis Lundy

  • Skincare/Cosmetics company I-NE (4933 JP) on 31 August (¥2947) announced it would move to TSE Prime on 19 September, and announced a Secondary Offering by CEO Onishi-san to get there.
  • There was no greenshoe provided. The stock popped. Then drifted back to ¥3025 and the Offering priced today at ¥2,934/share. 
  • 75% went to Asian/European (non-US) offshore investors, and the rest to onshore institutions, which is unusual. But now we look to the TOPIX inclusion.

Poly Culture (3636 HK): Pre-Condition Fulfilled

By Arun George

  • The pre-condition relating to Poly Culture Group Corp H (3636 HK)’s privatisation offer from Poly Group at HK$8.88 per H Share has been fulfilled. 
  • The key condition is approval by at least 75% of independent H Shareholders (<10% of all independent H Shareholders rejection). No independent H Shareholder holds a blocking stake.
  • The offer’s 77.6% premium to the undisturbed price and no minimum acceptance condition will help completion. At the last close and for 1 November completion, the gross/annualised spread is 7.1%/64.3%.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars